Matches in Nanopublications for { ?s ?p "[In normoglycaemic adults cutaneous microvascular vasodilatory capacity is associated with features of insulin resistance syndrome, particularly with plasminogen activator inhibitor type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630702.RAfdhm-8ZoHA1WP0syf_dl6ev8SyhVXBlLjXZottCCf6A130_assertion description "[In normoglycaemic adults cutaneous microvascular vasodilatory capacity is associated with features of insulin resistance syndrome, particularly with plasminogen activator inhibitor type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630702.RAfdhm-8ZoHA1WP0syf_dl6ev8SyhVXBlLjXZottCCf6A130_provenance.
- NP329891.RA-lBORWW8vFkSf5ji5rXeMj-8xKsU8rCsz3nRUcZGZpU130_assertion description "[In normoglycaemic adults cutaneous microvascular vasodilatory capacity is associated with features of insulin resistance syndrome, particularly with plasminogen activator inhibitor type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329891.RA-lBORWW8vFkSf5ji5rXeMj-8xKsU8rCsz3nRUcZGZpU130_provenance.
- assertion description "[In normoglycaemic adults cutaneous microvascular vasodilatory capacity is associated with features of insulin resistance syndrome, particularly with plasminogen activator inhibitor type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP329892.RAbkLMuLgVk2xz8j9-U1fi2zGvzshu6efGindEpeiztI4130_assertion description "[In normoglycaemic adults cutaneous microvascular vasodilatory capacity is associated with features of insulin resistance syndrome, particularly with plasminogen activator inhibitor type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329892.RAbkLMuLgVk2xz8j9-U1fi2zGvzshu6efGindEpeiztI4130_provenance.
- assertion description "[In normoglycaemic adults cutaneous microvascular vasodilatory capacity is associated with features of insulin resistance syndrome, particularly with plasminogen activator inhibitor type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP630463.RAh75DlWWT3ajn2qEnQd-NlWsNLCQ_8FRXYCuK7p1koKs130_assertion description "[In normoglycaemic adults cutaneous microvascular vasodilatory capacity is associated with features of insulin resistance syndrome, particularly with plasminogen activator inhibitor type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630463.RAh75DlWWT3ajn2qEnQd-NlWsNLCQ_8FRXYCuK7p1koKs130_provenance.